BioPharma Dive October 2, 2023
Mark Lambrecht, Senior Director, Health and Life Sciences Practice

When we start to talk about the use of open source technologies in life sciences, leaders fall into two main groups of thought: either we’re going all in on open source, or we’ll never compliantly be able to.

For the former, diving in to open source is exciting in the pursuit of building a more efficient life sciences ecosystem. From molecule discovery to trial enrollment and every step in between, the idea of using open source for innovation, increased speed and improved drug delivery is top of mind for many research teams.

At the same time, the latter group of thinking is still present: in order to maintain regulatory compliance, open source seems like a nonstarter. How could we include...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Analytics, Biotechnology, Pharma / Biotech, Technology
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article